CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 55 enrolled
Drug / intervention
Aspirin First +4 moredrug
Likely dose
Acetaminophen 1000 mg/dfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00646906
NCT00646906N/ACompleted

A Randomized, Double-Blind, Crossover Study to Evaluate the Mechanism of Action of Acetaminophen

University of Pennsylvania·interventional·Posted Mar 31, 2008·Updated Feb 12, 2026

In Brief

A clinical study evaluating Aspirin First, Aspirin Last, and 3 other interventions for Myocardial Infarction and Arthritis. Completed, enrolled 55 participants across 1 site.

Detailed Summary

This research study investigates whether the ability of aspirin to reduce the risk of heart attacks may be diminished by the administration of acetaminophen. Patients who have heart disease are often prescribed aspirin because of its unique ability to permanently prevent platelets from aggregating and forming a blood clot. Such blood clots cause heart attacks when they form in a blood vessel that supplies the heart with oxygen rich blood. Some of these same patients also take acetaminophen everyday for relief from arthritis pain. Higher doses of acetaminophen may also have the ability to prevent the platelets from clotting, however only temporarily. Therefore, this study evaluates whether the timing of the administration of acetaminophen (before or after aspirin) interferes with the permanent blood clotting effects of aspirin. The primary hypothesis is that acetaminophen given two hours before aspirin will antagonize the effects of aspirin, while reversing the order of administration will not.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 31, 2008
Enrollment StartJun 2, 2004
Primary CompletionJan 24, 2012
TodayJul 2, 2026
Enrollment to primary: 7.6 yearsPosted 18.3 years ago

Interventions

Aspirin Firstdrug

Crossover period Aspirin First: Subjects will receive 81 mg aspirin at approximately 8 am followed by acetaminophen at approximately 10 am.

Aspirin Lastdrug

Crossover period Aspirin Last: Subjects will receive acetaminophen at approximately 8 am followed by 81 mg aspirin at approximately 10 am.

Acetaminophen 1000 mg/ddrug

Subjects will receive a daily oral dose of 1000 mg acetaminophen for six days each administered at 8 AM.

Acetaminophen 4000 mg/ddrug

Crossover period Acetaminophen 4000 mg/d: Acetaminophen (1000 mg p.o.) orally at 8 AM, 2 PM, 8 PM and 2 AM for 3 days. The last dose will be administered on day four at 8 AM.

Ibuprofen 800 mg/ddrug

Crossover period Ibuprofen 800 mg/d: Ibuprofen (200 mg) orally at at 8 AM, 2 PM, 8 PM and 2 AM for 3 days. The last dose will be administered on day four at 8 AM.